Data / Drug companies / American Health Packaging
American Health Packaging: 496 products in the FDA NDC directory, labeler code 60687
Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).
American Health Packaging (labeler code 60687) lists 496 products in the FDA National Drug Code Directory, covering 246 finished drugs by generic name. By type: 476 prescription drugs, 20 over the counter drugs. Its main marketing category is generic drugs (ANDA). The newest product started marketing on November 1, 2026.
The request: Watch American Health Packaging (FDA labeler code 60687): each new product listing and each discontinued product. $10 of work on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Labeler code
- 60687
- Products in commercial distribution
- 496
- Packages
- 554
- Finished drugs by generic name
- 246
- Prescription products
- 476
- Over the counter products
- 20
- Controlled substance products
- Schedule II 24, Schedule III 4, Schedule IV 15, Schedule V 10
- Flagged as original packager
- 42 of 42 products that carry the flag
- Started marketing in the last 12 months
- 65
- Products with a marketing end date set
- 39
- Earliest marketing start
- May 12, 2015
- openFDA record search
- api.fda.gov
Products by marketing category
Share of the company's products in commercial distribution.
| Marketing category | Products | Share |
|---|---|---|
| Generic drugs (ANDA) | 470 | 94.8% |
| Over the counter monograph drugs | 17 | 3.4% |
| Other unapproved drugs | 3 | 0.6% |
| New drug applications (NDA) | 3 | 0.6% |
| Authorized generics (NDA) | 3 | 0.6% |
Products by type
| Type | Products | Share |
|---|---|---|
| Prescription drugs | 476 | 96% |
| Over the counter drugs | 20 | 4% |
Drugs it lists
Finished drugs by generic name, with how many companies list each.
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Tablet | 202 | 40.7% |
| Tablet, film coated | 102 | 20.6% |
| Capsule | 63 | 12.7% |
| Solution | 36 | 7.3% |
| Tablet, extended release | 19 | 3.8% |
| Suspension | 13 | 2.6% |
| Tablet, delayed release | 11 | 2.2% |
| Tablet, film coated, extended release | 7 | 1.4% |
| Capsule, extended release | 6 | 1.2% |
| Capsule, delayed release | 6 | 1.2% |
| Capsule, coated, extended release | 4 | 0.8% |
| Tablet, coated | 4 | 0.8% |
Pharmacologic classes
FDA established pharmacologic classes of its products.
Newest products
By marketing start date.
| Product | Product NDC | Dosage form | Marketing category | Marketing start |
|---|---|---|---|---|
| Buspirone hydrochloride | 60687-988 | Tablet | Generic drugs (ANDA) | November 1, 2026 |
| Methocarbamol | 60687-956 | Tablet, coated | Generic drugs (ANDA) | November 1, 2026 |
| Trospium Chloride | 60687-946 | Tablet, film coated | Generic drugs (ANDA) | November 1, 2026 |
| Methocarbamol | 60687-945 | Tablet, coated | Generic drugs (ANDA) | November 1, 2026 |
| Methotrexate | 60687-975 | Tablet | Generic drugs (ANDA) | October 29, 2026 |
| Trazodone Hydrochloride | 60687-965 | Tablet | Generic drugs (ANDA) | October 11, 2026 |
| Amlodipine Besylate | 60687-972 | Tablet | Generic drugs (ANDA) | October 1, 2026 |
| Amlodipine Besylate | 60687-961 | Tablet | Generic drugs (ANDA) | October 1, 2026 |
| Carbamazepine | 60687-973 | Tablet, extended release | Generic drugs (ANDA) | September 29, 2026 |
| Methadone Hydrochloride | 60687-910 | Tablet | Generic drugs (ANDA) | September 9, 2026 |
| Propranolol Hydrochloride | 60687-948 | Tablet | Generic drugs (ANDA) | September 1, 2026 |
| Voriconazole | 60687-979 | Tablet, film coated | Generic drugs (ANDA) | August 27, 2026 |
| Voriconazole | 60687-968 | Tablet, film coated | Generic drugs (ANDA) | August 27, 2026 |
| Esomeprazole Magnesium | 60687-934 | Capsule, delayed release | Generic drugs (ANDA) | August 19, 2026 |
| Lactulose | 60687-917 | Solution | Generic drugs (ANDA) | August 16, 2026 |
| Trazodone Hydrochloride | 60687-954 | Tablet | Generic drugs (ANDA) | August 14, 2026 |
| Valproic acid | 60687-953 | Solution | Generic drugs (ANDA) | August 4, 2026 |
| Valproic acid | 60687-942 | Solution | Generic drugs (ANDA) | August 4, 2026 |
| Dabigatran | 60687-963 | Capsule | Generic drugs (ANDA) | July 14, 2026 |
| Calcium Acetate | 60687-589 | Capsule | Generic drugs (ANDA) | July 5, 2026 |
| Dabigatran | 60687-974 | Capsule | Generic drugs (ANDA) | June 25, 2026 |
| Propranolol Hydrochloride | 60687-937 | Tablet | Generic drugs (ANDA) | June 23, 2026 |
| Lithium Carbonate | 60687-964 | Capsule | Generic drugs (ANDA) | June 14, 2026 |
| Bromocriptine Mesylate | 60687-931 | Tablet | New drug applications (NDA) | June 12, 2026 |
| Sacubitril and Valsartan | 60687-966 | Tablet, film coated | Generic drugs (ANDA) | June 11, 2026 |
CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.